William C. Dougall
Amgen (United States)(US)QIMR Berghofer Medical Research Institute(AU)
Publications by Year
Research Areas
Bone Metabolism and Diseases, Bone health and treatments, Cytokine Signaling Pathways and Interactions, NF-κB Signaling Pathways, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function(1997)2,294 cited
- → RANK is essential for osteoclast and lymph node development(1999)1,484 cited
- → The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain(1997)817 cited
- → Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab(2012)674 cited
- → RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis(2010)600 cited
- → Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL(2008)432 cited